Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
Valerio Rosato, Mario Masarone, Marcello Dallio, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 18, pp. 3415-3415
Open Access | Times Cited: 116

Showing 26-50 of 116 citing articles:

Association between serum trace element, mineral, and amino acid levels with non-alcoholic fatty liver disease (NAFLD) in adult women
Alexey A. Tinkov, Tatiana V. Korobeinikova, G.D. Morozova, et al.
Journal of Trace Elements in Medicine and Biology (2024) Vol. 83, pp. 127397-127397
Closed Access | Times Cited: 5
Insights on post-translational modifications in fatty liver and fibrosis progression
C. Nageswara Raju, Kavitha Sankaranarayanan
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167659-167659
Closed Access
Metabolic dysfunction-associated steatotic liver disease and increased risk of atrial fibrillation in the elderly: A longitudinal cohort study
Yehua Tang, Jianling Fan, Xingyun Hou, et al.
IJC Heart & Vasculature (2025) Vol. 58, pp. 101676-101676
Closed Access
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
Taeang Arai, Masanori Atsukawa, Akihito Tsubota, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Sexual Dysfunction in Patients With Chronic Gastrointestinal and Liver Diseases: A neglected Issue
Lorenzo Romano, L. Granata, Ferdinando Fusco, et al.
Sexual Medicine Reviews (2021) Vol. 10, Iss. 4, pp. 620-631
Closed Access | Times Cited: 29
Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
Stanislav Kotlyarov, Aleksei Bulgakov
Cells (2021) Vol. 10, Iss. 11, pp. 2978-2978
Open Access | Times Cited: 29
Non‐alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta‐analysis
Mohamed Shengir, Tianyan Chen, Elena Guadagno, et al.
JGH Open (2021) Vol. 5, Iss. 4, pp. 434-445
Open Access | Times Cited: 28
NAFLD in type 1 diabetes: overrated or underappreciated?
Jonathan Mertens, Luc F. Van Gaal, Sven Francque, et al.
Therapeutic Advances in Endocrinology and Metabolism (2021) Vol. 12
Open Access | Times Cited: 27
Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
Jaejun Lee, Taeyun Kim, Hyun Yang, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 2, pp. 196-206
Open Access | Times Cited: 20
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline
Stephan C. Bischoff, Johann Ockenga, Ahad Eshraghian, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 6, pp. 987-1024
Open Access | Times Cited: 12
Comorbid flow non-alcoholic fatty liver disease and osteoporosis
Л. А. Фомина
Medical alphabet (2025), Iss. 34, pp. 42-46
Closed Access
Urbanization as a Driving Factor of Global Burden of Non-Alcoholic Fatty Liver Disease: Based on the Global Burden of Disease Study 2021
Zejin Ou, Shi Chen, Ziyi Wang, et al.
(2025)
Closed Access
Drosophila melanogaster: A Powerful Tiny Animal Model for the Study of Metabolic Hepatic Diseases
Karen C. M. Moraes, Jacques Montagne
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 24
Triglyceride and glucose index: a useful tool for non-alcoholic liver disease assessed by liver biopsy in patients with metabolic syndrome?
Anca Maria Amzolini, Mircea-Cătălin Forțofoiu, Anca Barău Abu-Alhija, et al.
Romanian Journal of Morphology and Embryology (2022) Vol. 62, Iss. 2, pp. 475-480
Open Access | Times Cited: 17
Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
Sukrit Kanchanasurakit, Chayanis Kositamongkol, Kamonnat Lanoi, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 17
The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome
Zhongyang Lu, Yanchun Li, Nityananda Chowdhury, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8322-8322
Open Access | Times Cited: 10
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key
Marta Alonso‐Peña, María Del Barrio, Ana Peleteiro‐Vigil, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10718-10718
Open Access | Times Cited: 10
Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study
Kimiko Sakai, Takuro Okamura, Ema Toyokuni, et al.
Journal of Diabetes Investigation (2024)
Open Access | Times Cited: 3
TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population
Alba Martínez-Escudé, Guillem Pera, Anna Costa-Garrido, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2907-2907
Open Access | Times Cited: 20
Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease
Naiade Silveira Almeida, Raquel Rocha, Claudineia Almeida de Souza, et al.
World Journal of Hepatology (2022) Vol. 14, Iss. 8, pp. 1643-1651
Open Access | Times Cited: 15
Co-occurrence of non-alcoholic steatohepatitis exacerbates psoriasis associated with decreased adiponectin expression in a murine model
Daiki Takezaki, Shin Morizane, Kenta Ikeda, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives
Marcello Dallio, Mario Romeo, Antonietta Gerarda Gravina, et al.
Nutrients (2021) Vol. 13, Iss. 5, pp. 1679-1679
Open Access | Times Cited: 20
Agents for the treatment of fatty liver disease: focus on essential phospholipids
Asad Izziddin Dajani, A. Abu-Hammour
Drugs & Therapy Perspectives (2021) Vol. 37, Iss. 6, pp. 249-264
Open Access | Times Cited: 18
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets
Álvaro Santos‐Laso, María Gutiérrez‐Larrañaga, Marta Alonso‐Peña, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 46-46
Open Access | Times Cited: 18

Scroll to top